Return On Equity in % of Mereo BioPharma Group plc from 2023 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Mereo BioPharma Group plc quarterly/annual Return On Equity history and change rate from 2023 to Q3 2025.
  • Mereo BioPharma Group plc Return On Equity for the quarter ending 30 Sep 2025 was -75 %, a 58.9% increase year-over-year.
  • Mereo BioPharma Group plc annual Return On Equity for 2024 was -157 %, a 166% decline from 2023.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Mereo BioPharma Group plc Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -75 +107 +58.9% 01 Jul 2025 30 Sep 2025
Q2 2025 -193 -128 -197% 01 Apr 2025 30 Jun 2025
Q1 2025 -148 -95.2 -179% 01 Jan 2025 31 Mar 2025
Q4 2024 -157 -98.3 -166% 01 Oct 2024 31 Dec 2024
Q3 2024 -182 01 Jul 2024 30 Sep 2024
Q2 2024 -65 01 Apr 2024 30 Jun 2024
Q1 2024 -53.3 01 Jan 2024 31 Mar 2024
Q4 2023 -59.1 01 Oct 2023 31 Dec 2023

Mereo BioPharma Group plc Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -157 -98.3 -166% 01 Jan 2024 31 Dec 2024
2023 -59.1 01 Jan 2023 31 Dec 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.